Results 241 to 250 of about 7,424,540 (294)

Correction: Evaluation of QTc interval prolongation in patients with advanced clear cell renal cell carcinoma treated with first line sunitinib. [PDF]

open access: yesCancer Chemother Pharmacol
Sałek-Zań A   +7 more
europepmc   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell   +11 more
wiley   +1 more source

Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications. [PDF]

open access: yesWorld J Urol
McMaster T   +12 more
europepmc   +1 more source

Investigating the determinants of immunotherapy response in the primary tumour of clear cell renal cell carcinoma (RCC). [PDF]

open access: yesBMJ Oncol
Tang C   +8 more
europepmc   +1 more source

Metastatic tropism of molecularly defined clear-cell renal cell carcinoma clusters. [PDF]

open access: yesJ Clin Invest
Haddad G   +12 more
europepmc   +1 more source

Tumor-to-tumor metastasis of breast carcinoma to clear cell renal cell carcinoma: a rare case with a review of the literature. [PDF]

open access: yesCEN Case Rep
Nakajima N   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy